Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Isaac Ciechanover

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Bin Liu

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Xu Gillian

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Zhiyuan Zhou

Associate

Alex Zhou

Managing Partner

Yafeng Zhou

Associate

Zhifeng Zhou

Managing Partner

Phillip DiGiacomo Ph.D

Principal

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Past deals in Asia

Cornerstone Robotics

Series C in 2025
Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.

Dearer Medical

Venture Round in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

XellSmart

Series B in 2024
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Shanghai Mufan Power

Series B in 2024
Shanghai Mufan Power is a high-tech enterprise specializing in new energy solutions within the turbomachinery sector. The company focuses on developing advanced zero-carbon hydrogen power generation technologies and products, with its primary offering being hydrogen gas turbines. These turbines are designed for various applications, including distributed energy systems, data centers, rail transit, marine power, vehicle propulsion, and energy storage for peak shaving, all aimed at supporting carbon neutrality efforts. Mufan Power also engages in the design and development of significant national heavy equipment and provides technical consultation and engineering services related to gas turbines and steam turbines, ensuring that it meets the diverse needs of its clientele in China.

FXiaoKe

Venture Round in 2024
FXiaoKe is a Beijing-based company founded in December 2011 that specializes in developing a cloud-based sales management platform tailored for Chinese enterprises. The platform incorporates features of dynamic customer relationship management (CRM) and integrates seamlessly with enterprise WeChat, facilitating efficient collaboration among businesses, individuals, and systems. FXiaoKe’s software solutions support various management functions, including field operation management, distribution chain management, and customer relationship management, specifically targeting small and medium-sized enterprises. The platform is designed to enhance productivity by enabling users to manage sales through social interaction tools and offers online office automation services that facilitate information sharing between personal computers and smartphones. The company's focus encompasses a customer-centric approach with industry-specific strategies aimed at fostering growth in sectors such as high-tech, modern corporate services, fast-moving consumer goods, agriculture, and large-scale manufacturing.

SinoUnited Health

Series D in 2024
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.

Engitist

Series B in 2024
Engitist, established in 2018 and headquartered in Suzhou, China, specializes in the research, manufacturing, and sales of semiconductor optical measurement and testing equipment. Its product portfolio includes microscopic film measurement, optical defect detection, and optical linewidth measurement systems, catering to both domestic and international semiconductor customers seeking high-quality, accurate, and reliable inspection solutions.

Alpha Biopharma

Series B in 2024
Alpha Biopharma Inc. is a biopharmaceutical company based in Huangpu, China, focused on researching and developing innovative therapeutics. The company is primarily engaged in the clinical development of AZD3759, a small molecule tyrosine kinase inhibitor designed to treat patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) who have central nervous system metastases. Alpha Biopharma collaborates with prominent international pharmaceutical companies and utilizes a strong scientific consulting and management team to ensure rigorous research and development processes. The company emphasizes a multi-faceted approach to drug development, which includes research, market strategy, and intellectual property protection, while working closely with leading contract research organizations, contract manufacturing organizations, hospitals, and institutes to facilitate the orderly implementation of its projects.

DK Medtech

Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Dezhen Technology

Series C in 2024
Dezhen Technology provides solutions for medical institutions to help hospitals develop clinical, and scientific research management. Dezhen Technology is headquartered in Hongkou, China.

Yanshengchao

Angel Round in 2024
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China

Chunyu Yisheng

Venture Round in 2024
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.

Leapstack

Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

Yanshengchao

Angel Round in 2023
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China

Puanita

Series A in 2023
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

Cornerstone Robotics

Series B in 2023
Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.

Ailomics Therapeutics

Angel Round in 2023
Ailomics Therapeutics, established in 2022 with headquarters in Shanghai, China, specializes in developing novel drugs for treating immune diseases and tumors. The company employs a computational biology platform to analyze multi-omics patient data, aiming to uncover new drug targets and mechanisms driving disease progression.

CuroVax

Series B in 2023
CuroVax, established in 2011 and headquartered in Changzhou City, China, specializes in vaccine development and production. The company offers a range of vaccines, including a freeze-dried rabies vaccine for human use and an influenza virus split vaccine. CuroVax employs a dual approach of independent development and collaborative research, supported by multiple technology platforms such as large-scale mammalian cell culture and mRNA vaccine development. It provides biotechnology and microbiology services, focusing on improving health and medical industry standards.

DK Medtech

Venture Round in 2023
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Zeen Health

Series A in 2023
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

1 Yong Cloud

Series B in 2023
1 Yong Cloud is a Beijing-based company founded in 2017 that specializes in developing and operating a tumor diagnosis and treatment standardization platform. The platform is designed to assist healthcare professionals in formulating personalized diagnosis and treatment plans for patients with tumor diseases. By collecting and translating medical data, 1 Yong Cloud aims to enhance the quality and standardization of medical practices while rationalizing treatment expenses. Through its comprehensive data and system services, the company supports physicians in making informed decisions to improve patient outcomes.

Puanita

Pre Seed Round in 2023
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

Ricoton

Series A in 2023
Ricoton is a medical device company based in Hunan, China, specializing in the development and production of devices for cerebrovascular diseases. Founded in 2011, the company offers a range of products designed for interventional medicine, including microcatheters, guidewires, and various vascular access devices. Notably, Ricoton's equipment features a comprehensive set that includes a micro guide wire, micro catheter, support catheter, thrombectomy stent, balloon guide catheter, and intracranial balloon dilatation catheter. This innovative lineup provides a one-stop thrombectomy solution aimed at enhancing the treatment and prevention of cerebrovascular conditions.

Allorion Therapeutics

Series B in 2023
Allorion Therapeutics is a small molecule therapeutic development company specializing in the treatment of cancer and autoimmune diseases. With operations in Natick, Massachusetts, and Guangzhou, China, Allorion focuses on creating mutant selective and isoform-specific drugs through innovative methods targeting established medical challenges. By concentrating on enhancing drug efficacy and preventing resistance in patients, the company aims to improve therapeutic outcomes in these critical areas of healthcare.

Xinchuangyuan Semiconductor

Series A in 2023
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.

SinoUnited Health

Series C in 2023
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.

Biotree Technology

Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Tlibrium

Angel Round in 2022
Tlibrium provides expertise in the technology promotion and application service industry. Tlibrium was founded in 2022 and was headquartered in Shanghai, China.

Bio-Link

Series A in 2022
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.

Sunny Dental

Series A in 2022
Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a comprehensive range of orthodontic services. The company provides diagnosis and treatment for dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp issues, and oral and maxillofacial surgery. Sunny Dental is dedicated to offering professional care and advanced solutions in various aspects of dental health, ensuring a focus on both preventative and restorative treatments.

PureVision

Series A in 2022
PureVision focuses on developing medical devices for ophthalmology. PureVision was founded in 2022 and was headquartered in Wenzhou, Zhejiang China.

PlusLife Biotech

Series A in 2022
PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.

Bitworx

Series A in 2022
Bitworx is a technology company headquartered in Chengdu, China, specializing in product development and applications that leverage advanced algorithm and chip technology. The company's focus is on enhancing communication, sensing, and detection capabilities. Currently, Bitworx is operating in stealth mode, which indicates a strategic approach to its operations and product offerings, allowing for innovation and development away from public scrutiny. Through its expertise in cutting-edge technology, Bitworx aims to create solutions that meet emerging demands in various sectors.

Intellinosis

Angel Round in 2022
Intellinosis is a diagnostic company that focuses on developing molecular diagnostic reagents. Intellinosis is headquartered in Minhang District, China.

Dezhen Technology

Series A in 2022
Dezhen Technology provides solutions for medical institutions to help hospitals develop clinical, and scientific research management. Dezhen Technology is headquartered in Hongkou, China.

XellSmart

Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Focallure

Series B in 2022
Focallure is a cosmetic company headquartered in Guangzhou, China, specializing in the development and manufacturing of makeup products. The company emphasizes base makeup and a variety of cosmetics, utilizing big data analysis to enhance its operations. By analyzing consumer product preferences and social content trends, Focallure aims to provide users with an innovative and refreshing makeup experience.

KouTech

Series A in 2022
KouTech develops surgical robots that can perform ophthalmic surgery, trans-gastroscopic, and general-purpose microsurgery. KouTech was founded in 2022 and was headquartered in Shanghai, China.

Prismlab China

Series C in 2022
Prismlab China Ltd. is a high-tech enterprise established in 2005, specializing in the development, production, and sales of high-speed light-curing 3D printers. The company integrates optical, mechanical, and electrical technology with computer software and hardware, alongside photopolymer materials. Prismlab's primary focus is on research and development, manufacturing, and marketing of rapid prototyping machines utilizing stereolithography (SLA) technology. Its innovative products are recognized for their quality and performance, reaching customers in over 50 countries and regions, and have garnered critical acclaim from users around the globe.

Ailomics Therapeutics

Seed Round in 2022
Ailomics Therapeutics, established in 2022 with headquarters in Shanghai, China, specializes in developing novel drugs for treating immune diseases and tumors. The company employs a computational biology platform to analyze multi-omics patient data, aiming to uncover new drug targets and mechanisms driving disease progression.

Norm Medtech

Series B in 2022
Norm Medtech focuses on developing interventional medical devices. Norm Medtech is headquartered in Zhejiang, China.

Tasogare

Series C in 2022
Tasogare Coffee is a premium coffee brand located in Japan that specializes in producing and supplying a diverse range of coffee products. The company operates through both online and retail channels, ensuring accessibility for its customers. With a commitment to quality, Tasogare Coffee aims to deliver an exceptional coffee experience, appealing to discerning coffee enthusiasts.

OriginCell

Series B in 2022
Shanghai Origincell Biological Cryo Equipment Co., Ltd. is a biomedical enterprise established in 2014, headquartered in Shanghai, China. The company specializes in immunological cell collection, separation, and storage services. It manufactures biobanking storage devices, including cryogenic freezers and biobank systems. In addition to its storage solutions, Origincell develops tumor immunotherapy solutions, utilizing advanced technologies such as the 10-phage display library and humanized antibody technology. These innovations support medical facilities in their cancer treatment efforts, positioning Origincell as a key player in the intersection of biobanking and cancer therapy.

Qingflow

Series B in 2022
Qingflow is a software-as-a-service platform based in Minhang District, Shanghai, that specializes in business workflow management solutions. The company offers a customizable platform that allows users to design and combine various modules to create personalized management systems tailored to their specific needs. This user-friendly approach enables individuals and organizations to build their own business management systems without requiring any programming skills, making it accessible for a wide range of users seeking to enhance their operational efficiency.

Biotree Technology

Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Resunbio

Series A in 2022
Resunbio provides micro-nano processing research and development precipitation. Resunbio is headquartered in Longhua, China.

Puanita

Angel Round in 2022
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

Wayon

Funding Round in 2022
WayOn is a Shanghai-based company established in 1996 that specializes in electronic circuit protection and power semiconductor solutions for industrial applications. The company offers a diverse range of products, including PPTC, CPTC, and chip fuses for over-current protection, as well as TVS, thyristors, and ESD devices for over-voltage protection. Additionally, WayOn provides thermal fuses for over-temperature protection and a variety of power management components such as Battery Management Systems, MOSFETs, and protection integrated circuits. Its product applications span multiple sectors, including telecommunications, rechargeable batteries, IT equipment, automotive electronics, industrial machinery, and consumer electronics. By delivering reliable and efficient solutions, WayOn serves a broad clientele across these industries.

Yanshengchao

Seed Round in 2022
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China

MediLink Therapeutics

Series B in 2022
MediLink Therapeutics is a biotechnology company with a research and development center located in Suzhou, China. The company specializes in the development of next-generation antibody-drug conjugates (ADCs) aimed at treating cancer more effectively. MediLink Therapeutics is dedicated to addressing significant unmet medical needs within China and seeks to create global value through multicenter clinical trials and cross-border collaborations. By focusing on ADC therapeutics, the company aims to provide cancer patients with treatments that target cancerous cells while minimizing harm to healthy cells, thereby enhancing patient well-being during treatment.

Wowjoy Technology

Series A in 2022
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.

Xiaoniao Kuaiyan

Series A in 2022
Xiaoniao Kuaiyan is a Beijing-based company that specializes in home physical examination services. It offers a range of health-related services, including regular check-ups, tumor screening, infection tests, chronic disease surveillance, and customized health assessments. In addition to its core services, the company facilitates business cooperation between enterprises and provides customer service and professional training. Xiaoniao Kuaiyan also focuses on quality management by formulating procedures for quality inspection and developing a comprehensive product knowledge base.

Eigencomm

Series C in 2022
Eigencomm Ltd. is a Shanghai-based company established in 2017 that specializes in the research, development, and sales of cellular network internet chips. The company focuses on creating turnkey solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. Eigencomm offers standard NB-IoT terminal chips that ensure comprehensive cellular data connectivity and extended standby durations, positioning itself as a key player in the cellular IoT market.

Tungee

Series B in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

Sinogen Biopharma

Venture Round in 2021
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.

Xinchuangyuan Semiconductor

Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.

SUPERHEXA

Series A in 2021
Superhexa is a Beijing-based hardware company founded on October 15, 2020, by Xia Yongfeng. The firm specializes in developing innovative personal consumer electronics designed to seamlessly integrate technology into everyday life. By focusing on enhancing user experiences, Superhexa aims to create products that cater to the evolving needs of consumers in a technology-driven world.

Clinflash Heathcare Technology

Venture Round in 2021
Clinflash is a leading provider of cloud-based solution and relevant professional service in filed of clinical development in China. Clinflash aims to help pharmaceutical companies improve R&D effectiveness and efficiency through providing first class IT solution and professional service.

Allorion Therapeutics

Series A in 2021
Allorion Therapeutics is a small molecule therapeutic development company specializing in the treatment of cancer and autoimmune diseases. With operations in Natick, Massachusetts, and Guangzhou, China, Allorion focuses on creating mutant selective and isoform-specific drugs through innovative methods targeting established medical challenges. By concentrating on enhancing drug efficacy and preventing resistance in patients, the company aims to improve therapeutic outcomes in these critical areas of healthcare.

Cornerstone Robotics

Series B in 2021
Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.

GenLight Medical

Series B in 2021
GenLight Medical is a company based in Hangzhou, China, that specializes in developing innovative treatment solutions for epilepsy and other neurological disorders. The firm focuses on creating advanced laser medical equipment and technologies aimed at improving patient outcomes in the fields of brain science and neurosurgery. Among its notable advancements are brain-computer control technology, full-cranial implantation techniques for deep brain nerve stimulation, brain computer chips, and systems for magnetic resonance guided laser ablation, which facilitate minimally invasive surgical procedures. GenLight Medical is committed to providing high-end, technologically advanced solutions for patients requiring brain surgery.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

Qingflow

Series B in 2021
Qingflow is a software-as-a-service platform based in Minhang District, Shanghai, that specializes in business workflow management solutions. The company offers a customizable platform that allows users to design and combine various modules to create personalized management systems tailored to their specific needs. This user-friendly approach enables individuals and organizations to build their own business management systems without requiring any programming skills, making it accessible for a wide range of users seeking to enhance their operational efficiency.

Genevide

Angel Round in 2021
Genevide is a biotech company established in 2019 and based in Suzhou, Jiangsu, China. The company focuses on gene research and development, specifically addressing challenges in nucleic acid detection. Genevide has developed a molecular enzyme cycle screening platform that includes enzyme-mediated one-step sample processing technology and enzyme-mediated double exponential amplification nucleic acid detection technology. These innovations aim to enhance the accessibility and efficiency of nucleic acid detection for researchers.

XellSmart

Seed Round in 2021
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Wowjoy Technology

Series A in 2021
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.

PlusLife Biotech

Series A in 2021
PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.

Berry Oncology

Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

Neuro3 Therapeutics

Seed Round in 2021
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

SUPERHEXA

Seed Round in 2021
Superhexa is a Beijing-based hardware company founded on October 15, 2020, by Xia Yongfeng. The firm specializes in developing innovative personal consumer electronics designed to seamlessly integrate technology into everyday life. By focusing on enhancing user experiences, Superhexa aims to create products that cater to the evolving needs of consumers in a technology-driven world.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Insight Lifetech

Series D in 2021
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

WeRide

Series C in 2021
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

Hesai Technology

Series D in 2021
Hesai Technology is a company based in Shanghai, China, founded in 2014. It specializes in designing laser radar systems using smart sensing technology. The primary application of these systems is to facilitate autonomous driving by enabling car companies to monitor mixed gas composition and detect hazardous leaks. Additionally, Hesai Technology develops natural gas leak detection systems for industrial processes. Its LiDAR products are used in a variety of applications including advanced driver assistance systems (ADAS), autonomous vehicle fleets, last-mile delivery robots, street sweeping robots, and logistics robots. The company operates through two main segments: the LiDAR segment and the gas detection segment, with the former being the primary revenue generator.

Insight Lifetech

Secondary Market in 2021
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Data Transmission Group

Secondary Market in 2021
Data Transmission Group is an Internet technology group focusing on big data services in the press and publishing industry. Data Transmission Group is committed to the digital transformation and upgrading of big data services in the press and publication industry and the digital transformation and upgrading of the media industry, creating a digital content profit model with content providers as the main commercial value, changing the way users acquire and disseminate knowledge, and leading the Internet + upgrade of China's news and publications Replacement and industrial development direction. At present, the group has nearly 200 employees, most of whom are senior publishing, Internet, and software R&D personnel. They have a complete independent R&D system and have rich research results in mobile Internet technology, storage technology, data mining, and publishing integration.

Render

Series A in 2021
Render is a Chinese manufacturer of high-tech medical products and solutions. Render is a Shenzhen-based company that was founded in 2010.

Tungee

Series C in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

P&R Measurement Technology

Series C in 2021
P&R Measurement Technology Co., Ltd. is a Chinese company specializing in the research, development, and supply of testing and automation solutions. Established in 2011 and headquartered in the Bai Jiao Science and Technology Industrial Park in Zhuhai, the company serves various sectors, including motors, household appliances, consumer electronics, and energy power. It leverages its expertise in engineering signal processing, acoustic and vibration testing, and structural analysis to provide customized and semi-custom engineering testing equipment, data processing tools, and consulting services. P&R Measurement Technology also maintains a presence through subsidiaries in Guangzhou, Suzhou, Hong Kong, and the United States, along with offices in several Chinese cities, including Qingdao, Hefei, Shunde, and Ningde.

Tasogare

Series B in 2021
Tasogare Coffee is a premium coffee brand located in Japan that specializes in producing and supplying a diverse range of coffee products. The company operates through both online and retail channels, ensuring accessibility for its customers. With a commitment to quality, Tasogare Coffee aims to deliver an exceptional coffee experience, appealing to discerning coffee enthusiasts.

SinoUnited Health

Series C in 2021
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.

CastBox

Series C in 2021
CastBox is a Beijing-based company, founded in 2016, that operates a spoken audio platform, providing users with access to a diverse range of podcasts, on-demand radio, and audiobooks. The platform enables listeners to discover content through advanced audio search capabilities, which tailor recommendations based on individual preferences and habits. Users can access the service through a mobile application compatible with various devices, including desktops and smart home devices. CastBox incorporates proprietary technology that employs natural language processing and machine learning to enhance the listening experience, allowing for deep search capabilities and curated podcast suggestions in multiple languages. With a focus on making spoken audio content easily discoverable and enjoyable, CastBox aims to serve a global audience from its offices in Beijing, Hong Kong, and San Francisco.

Xizi Education

Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.

ZSHK Laboratories

Series A in 2021
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.

Sincere Edu

Series A in 2021
Sincere Edu is an online education company based in Beijing, China, founded in 2016. It specializes in providing educational services for finance professionals, with a focus on CPA exam preparation. The company offers courses covering subjects such as accounting, tax laws, economics, financial management, and audit. Sincere Edu aims to create a comprehensive learning platform that supports financial professionals throughout their careers by sharing knowledge and cultivating a robust teacher training system.

ET Healthcare

Series G in 2021
ET Healthcare, Inc. is an in vitro diagnostics company specializing in the development and manufacturing of central laboratory analyzers designed for both inpatient and outpatient testing across various medical settings, including hospitals and clinics. The company's flagship product, the Pylon Immunochemistry System, integrates a central laboratory analyzer tailored for point-of-care testing, addressing diverse immunodiagnostic needs such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, ET Healthcare offers the Pylon BNP Immunoassay, which aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. With a focus on improving diagnostic efficiency and reducing the complexity of testing environments, the company aims to provide high-sensitivity tests while minimizing space and resource requirements. Headquartered in Palo Alto, California, ET Healthcare also operates offices in Shanghai, China, and has manufacturing facilities in Suzhou, China.

Unisound

Series D in 2021
Beijing Yunzhisheng Information Technology Co., Ltd., also known as Unisound, is a Chinese startup established in June 2012, specializing in intelligent voice and speech processing technologies. The company has developed proprietary speech recognition technologies and utilizes cloud computing to deliver a range of middleware and cloud platforms for speech recognition services. Unisound's offerings cater to both internet enterprises and individual users, providing professional solutions for voice recognition. The core technology team is composed of highly qualified professionals, with over 80% holding doctoral degrees and possessing extensive experience in voice recognition research and development. Additionally, Unisound focuses on Internet of Things (IoT) and artificial intelligence (AI) technologies, enabling efficient communication between users and machines through voice commands, thereby minimizing the need for manual input.

Alpha Biopharma

Series B in 2021
Alpha Biopharma Inc. is a biopharmaceutical company based in Huangpu, China, focused on researching and developing innovative therapeutics. The company is primarily engaged in the clinical development of AZD3759, a small molecule tyrosine kinase inhibitor designed to treat patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) who have central nervous system metastases. Alpha Biopharma collaborates with prominent international pharmaceutical companies and utilizes a strong scientific consulting and management team to ensure rigorous research and development processes. The company emphasizes a multi-faceted approach to drug development, which includes research, market strategy, and intellectual property protection, while working closely with leading contract research organizations, contract manufacturing organizations, hospitals, and institutes to facilitate the orderly implementation of its projects.

Fucunbao

Series C in 2021
Fucunbao is a company that develops and operates an online platform focused on providing insurance and medical services, primarily serving rural communities in China. Their application offers solutions for medical management, enabling users to purchase insurance online, set up reimbursement plans, and identify disease types digitally. By leveraging government funding and resources, Fucunbao subsidizes insurance and medical expenses, aiming to reduce poverty stemming from healthcare challenges in these areas.

MediLink Therapeutics

Series A in 2021
MediLink Therapeutics is a biotechnology company with a research and development center located in Suzhou, China. The company specializes in the development of next-generation antibody-drug conjugates (ADCs) aimed at treating cancer more effectively. MediLink Therapeutics is dedicated to addressing significant unmet medical needs within China and seeks to create global value through multicenter clinical trials and cross-border collaborations. By focusing on ADC therapeutics, the company aims to provide cancer patients with treatments that target cancerous cells while minimizing harm to healthy cells, thereby enhancing patient well-being during treatment.

Hangzhou Weier

Series B in 2021
Hangzhou Weier Technology Co., Ltd, also known as Weier Science, specializes in the design and development of robots and software that enhance human-machine interaction. Founded in 2016 and headquartered in Hangzhou, China, the company operates within the augmented and virtual reality sectors. Weier Technology focuses on artificial intelligence and natural language processing to create customer service robots that assist e-commerce platforms. These robots can answer customer inquiries, generate customer profiles, and analyze data to improve service delivery, ultimately helping businesses better understand and engage with their clients.

XSKY Data Technology

Series E in 2021
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise needs.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Erwan Technology

Series D in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.

Erwan Technology

Series E in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.

WeRide

Series B in 2021
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.

Kira Pharmaceuticals

Series B in 2021
Kira Pharmaceuticals, established in 2017 and headquartered in Suzhou, China, is a biotechnology company focused on developing innovative therapies targeting the complement system to treat immune-mediated diseases.

Abbisko Therapeutics

Series D in 2021
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on the discovery, development, and manufacturing of innovative immuno-oncology therapies. Founded in 2016 by a team of experienced professionals from leading pharmaceutical companies, Abbisko is dedicated to developing small molecule inhibitors, including ABSK011 and ABSK021, for the treatment of hepatocellular carcinoma, as well as CSF1R for solid tumors. In addition to oncology, the company is engaged in developing therapeutics for various conditions, including cancer, liver diseases, diabetes, metabolic disorders, viral infections, and central nervous system diseases.

Cornerstone Robotics

Series A in 2021
Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.